Heparin oligosaccharides: Inhibitors of the biological activity of bFGF on Caco-2 cells

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 9-16

  Jayson, G C ^a   Gallagher, J T ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Basic fibroblast growth factor; Heparan sulphate; Heparin; Inhibition; Low molecular weight heparin; Oligosaccharide

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARAN SULFATE; HEPARIN; MITOGENIC AGENT; OLIGOSACCHARIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL MIGRATION; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0031032234     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.3     Document Type: Article

References (31)

1. Aviezer D, Levy E, Safran C, Svahn C, Buddecke E, Schmidt A, David G, Vlodavsky I and Yayon A (1994) Differential structural requirements of heparin and heparan sulphate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J Biol Chem 269: 114-121
2. Association of Cancer Physicians (1994) Review of the Pattern of Cancer Services in England and Wales. Association of Cancer Physicians: London
3. Baeuerle PA and Huttner WB (1986) Chlorate - a potent inhibitor of protein sulphation in intact cells. Biochem Biophys Res Commun 141: 870-877
4. Bara L, Billaud E, Gramond G, Kher A and Savana M (1985) Comparative pharmacokinetics of a low molecular weight heparin (PK10169) and unfractionated heparin after intravenous und subcutaneous administration. Thromb Res 39: 631-636
5. Coltrini D, Rusnati M, Zoppeti G, Oreste P, Grazioli G, Naggi A and Presta M (1994) Differential effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor. Biochem J 303: 583-590
6. Eisenberger MA, Reyno LM, Jodrell DI, Sinibaldi VJ, Tkaczuk KH, Sridhara R, Zuhowski EG, Lowitt MH, Jacobs SC and Egorin MJ (1993) Suramin, an active drug for prostate cancer: interim observations in a phase I trial. J Natl Cancer Inst 85: 611-621
7. Gitay-Goren H, Soker S, Vlodavsky I and Neufeld G (1992) The binding of vascular endothelial growth factor to its receptors is dependent on cell surface associated heparin like molecules. J Biol Chem 267: 6093-6098
8. Guimond S, Maccarana M, Olwin BB, Lindahl U and Rapraeger AC (1993) Activating and inhibitory heparan sequences for FGF-2 (basic FGF). J Biol Chem 268: 23906-23914
9. Hahnenburger R, Jakobsen AM, Ansari A, Wehler T, Svahn CM and Lindahl U (1993) Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis. Glycobiology 3: 567-573
10. Higashiyama S, Abraham JA and Klagsbrun M (1993) Heparin-binding EFG-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulphate. J Cell Biol 122: 933-940
11. Hirsh J and Levine MN (1992) Low molecular weight heparin. Blood 29: 1-17
12. Ishihara M (1994) Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2. Glycobiology 4: 817-824
13. Ishihara M, Tyrell DJ, Stauber GB, Brown S, Cousens LS and Stack RJ (1993) Preparation of affinity fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. J Biol Chem 268: 4675-4683
14. Ishihara M, Shaklee PN, Yang Z, Liang W, Wei Z, Stack RJ and Holme K (1994) Structural features in heparin which midulate specific biological activities by basic fibroblast growth factor. Glycobiology 4: 451-458
15. Jayson GC, Evans GS, Pemberton PW, Lobley RW and Allen T (1994) Basic fibroblast growth factor increases the multiplication and migration of a serum tree derivative of Caco-2 but does not affect differentiation. Cancer Res 54: 5718-5723
16. Kan M, Wang F, Xu J, Crabb JW, Hon J and McKeehan WI (1993) An essential heparin-binding domain in the fibroblast growth factor receptor kinase. Science 259: 1918-1921
17. Lyon M, Deakin JA and Gallagher JT (1994a) Liver heparan sulphate structure. J Biol Chem 269: 11208-11215
18. Lyon M, Deakin JA, Mizuno K, Nakamura T and Gallagher JT (1994b) Interaction of hepatocyte growth factor with heparan sulphate. J Biol Chem 269: 11216-11223
19. Maccarana M, Casu B and Lindahl U (1993) Minimal sequence in heparin/heparan sulphate required for binding of basic fibroblast growth factor. J Biol Chem 268: 23898-23905
20. Mustonen T and Alitalo K (1995) Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 129: 895-898
21. Myers C, Cooper M, Stein C, Larocca R, Walther MM, Weiss G, Choyke P, Dawson N, Steinberg S, Uhrich MM, Cassidy J, Kohler DR, Trepel J and Linehan WM (1992) Suramin: a novel growth factor antagonist with activity in hormone refractory prostate cancer. J Clin Oncol 10: 881-889
22. Olwin B and Rapraeger A (1992) Repression of myogenic differentiation by aFGF, bFGF and K-FGF is dependent on cellular heparan sulphate. J Cell Biol 118: 631-639
23. Ornitz DM, Yayon A, Flanagan JG, Svahn CM, Levi E and Leder P (1992) Heparin is required for cell free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol Cell Biol 12: 240-247
24. Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn CM and Waksman G (1995) FGF binding and FGF receptor activation by synthetic heparin-derived di- and trisaccharides. Science 268: 432-436
25. Prestrelski SJ, Fox GM and Arakawa T (1992) Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch Biochem Biophys 293: 314-319
26. Rapraeger A, Krufka A and Olwin BB (1991) Requirement of heparan sulphate for bFGF mediated fibroblast growth and myoblast differentiation. Science 252: 1705-1707
27. Shively JE and Conrad HE (1976) Formation of anhydrosugars in the chemical depolymerisation of heparin. Biochemistry 15: 3932-3942
28. Turnbull JE and Gallagher JT (1991) Distribution of iduronate 2-sulphate residues in heparan sulphate. Evidence for an ordered polymeric structure. Biochem J 273: 553-559
29. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC and Gallagher JT (1992) Identification of the basic fibroblast factor binding sequence in fibroblast heparan sulphate. J Biol Chem 267: 10337-10341
30. Walker A, Turnbull JE and Gallagher JT (1994) Specific heparan sulphate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem 269: 931-935
31. Yayon A, Klagsbrun M, Esko JD, Leder P and Omitz DM (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64: 841-848